A switch in enantiomer preference between mitochondrial F1F0-ATPase chemotypes

被引：10
|
作者：
Bisaha, SN
Malley, MF
Pudzianowski, A
Monshizadegan, H
Wang, P
Madsen, CS
Gougoutas, JZ
Stein, PD
机构：
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Discovery Chem, Princeton, NJ 08543 USA
[2] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Solid State Struct, Princeton, NJ 08543 USA
[3] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Comp Aided Drug Design, Princeton, NJ 08543 USA
[4] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Cardiovasc Biol, Princeton, NJ 08543 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 11期
关键词：
mitochondrial ATPase; acylguanidine; chiral synthesis;
D O I：
10.1016/j.bmcl.2005.03.115
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The preferred absolute configuration of two series of F1F0-ATP synthase inhibitors was determined. Although the configuration of the active enantiomer in each series is different, each series presents the same 'triaryl' pharmacophore to the enzyme binding site. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2749 / 2751
页数：3
相关论文
共 50 条
  • [21] Thiol oxidation is crucial in the desensitization of the mitochondrial F1F0-ATPase to oligomycin and other macrolide antibiotics
    Nesci, Salvatore
    Ventrella, Vittoria
    Trombetti, Fabiana
    Pirini, Maurizio
    Pagliarani, Alessandra
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2014, 1840 (06): : 1882 - 1891
  • [22] Yeast mitochondrial F1F0-ATPase: the novel subunit e is identical Tim11
    Arnold, I
    Bauer, MF
    Brunner, M
    Neupert, W
    Stuart, RA
    FEBS LETTERS, 1997, 411 (2-3) : 195 - 200
  • [23] THE BETA-SUBUNIT OF THE F1F0-ATPASE IS CONSERVED IN MYCOPLASMAS
    ZILBERSTEIN, D
    SHIRVAN, MH
    BARILE, MF
    ROTTEM, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1986, 261 (16) : 7109 - 7111
  • [24] Preparation of Novel Pyrazolyl Guanidine as F1F0-ATPase Inhibitors
    Rosse, Gerard
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (12): : 952 - 952
  • [25] Excessive ATP hydrolysis in ischemic myocardium by mitochondrial F1F0-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activity
    Grover, GJ
    Atwal, KS
    Sleph, PG
    Wang, FL
    Monshizadegan, H
    Monticello, T
    Green, DW
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 287 (04): : H1747 - H1755
  • [26] Sulfite inhibits the F1F0-ATP synthase and activates the F1F0-ATPase of Paracoccus denitrificans
    Pacheco-Moisés, F
    Minauro-Sanmiguel, F
    Bravo, C
    García, JJ
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2002, 34 (04) : 269 - 278
  • [27] Sulfite Inhibits the F1F0-ATP Synthase and Activates the F1F0-ATPase of Paracoccus denitrificans
    Fermín Pacheco-Moisés
    Fernando Minauro-Sanmiguel
    Concepción Bravo
    José J. García
    Journal of Bioenergetics and Biomembranes, 2002, 34 : 269 - 278
  • [28] F1F0-ATPase activity and ATP dependence of mitochondrial energization in proximal tubules after hypoxia/reoxygenation
    Feldkamp, T
    Kribben, A
    Weinberg, JM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (06): : 1742 - 1751
  • [29] Insertion of mitochondrial DNA-encoded F1F0-ATPase subunit 8 across the mitochondrial inner membrane in vitro
    Ii, M
    Mihara, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (27) : 24704 - 24712
  • [30] Identification and validation of the mitochondrial F1F0-ATPase as the molecular target of the immunomodulatory benzodiazepine Bz-423
    Johnson, KM
    Chen, XN
    Boitano, A
    Swenson, L
    Opipari, AW
    Glick, GD
    CHEMISTRY & BIOLOGY, 2005, 12 (04): : 485 - 496
12345